Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anti-scl-70.

Dhiman Basu1, John D Reveille

  • 1Division of Rheumatology and Clinical Immunogenetics, The University of Texas-Houston Health Science Center, 77030, USA.

Autoimmunity
|April 5, 2005
PubMed
Summary

Anti-Scl-70 autoantibodies are valuable for diagnosing systemic sclerosis (SSc) and predicting disease severity, particularly diffuse cutaneous involvement and lung disease. Testing aids in distinguishing SSc patients from other conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of comorbidities and extra-musculoskeletal manifestations on radiographic progression in ankylosing spondylitis.

Rheumatology (Oxford, England)·2026
Same author

Safety and Efficacy of Intravenous Golimumab in Adults with Ankylosing Spondylitis: Results through 1 Year of the GO-ALIVE Study.

The Journal of rheumatology·2026
Same author

Safety and Efficacy of Golimumab Administered Intravenously in Adults with Ankylosing Spondylitis: Results through Week 28 of the GO-ALIVE Study.

The Journal of rheumatology·2026
Same author

A highly prevalent lupus risk haplotype increases IRF7-dependent induction of IFN-α, enhancing antiviral defense and exacerbating autoimmunity.

medRxiv : the preprint server for health sciences·2026
Same author

Does HLA-B27 Status Influence Ixekizumab Efficacy in Axial Spondyloarthritis? Results From the COAST-V, COAST-W, and COAST-X Trials.

Rheumatology and therapy·2025
Same author

Global epidemiology of spondyloarthritis.

Nature reviews. Rheumatology·2025

Area of Science:

  • Rheumatology
  • Immunology
  • Autoantibodies

Background:

  • Autoantibodies, such as anti-Scl-70 (topoisomerase I), play a crucial role in diagnosing and managing rheumatic diseases.
  • Understanding the diagnostic utility of anti-Scl-70 is essential for accurate patient stratification.

Observation:

  • Anti-Scl-70 autoantibodies effectively differentiate systemic sclerosis (SSc) patients from healthy individuals and those with other connective tissue diseases.
  • Positivity for anti-Scl-70 in SSc patients can indicate a higher risk of diffuse cutaneous manifestations and interstitial lung disease.

Findings:

  • Immunodiffusion is the most validated method for anti-Scl-70 detection, while ELISAs show variable specificity, though newer versions are improving.
  • While anti-Scl-70 is useful for diagnosis and prognosis, the need for serial testing remains unestablished.

Implications:

  • Anti-Scl-70 autoantibody testing is a key diagnostic and prognostic tool in the clinical management of systemic sclerosis.
  • This biomarker aids in identifying patients who may benefit from targeted therapies for diffuse SSc and associated lung complications.

Related Experiment Videos